Assignee
GENUS LIFESCIENCES INC
US·24 granted patents·1 pending application·112 citations·filing 2017–2023
Top patents by PatentIndex Score
25 records- 0197US10933060B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2020·Granted Mar 2, 2021·5 cites·12 claims
- 0297US10857095B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2020·Granted Dec 8, 2020·7 cites·12 claims
- 0396US10894012B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2020·Granted Jan 19, 2021·5 cites·14 claims
- 0495US10413505B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2018·Granted Sep 17, 2019·9 cites·16 claims
- 0595US10231961B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2017·Granted Mar 19, 2019·10 cites·23 claims
- 0693US11040032B2Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2018·Granted Jun 22, 2021·3 cites·8 claims
- 0793US10987347B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2019·Granted Apr 27, 2021·3 cites·8 claims
- 0893US9867815B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2017·Granted Jan 16, 2018·16 cites·28 claims
- 0992US11071739B1Oral liquid compositions including chlorpromazineGENUS LIFESCIENCES INC·Filed 2020·Granted Jul 27, 2021·7 cites·21 claims
- 1092US10420760B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2018·Granted Sep 24, 2019·9 cites·20 claims
- 1192US10016407B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2017·Granted Jul 10, 2018·10 cites·20 claims
- 1291US10149843B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2017·Granted Dec 11, 2018·10 cites·14 claims
- 1390US11911502B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2021·Granted Feb 27, 2024·1 cites·5 claims
- 1490US11738015B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2021·Granted Aug 29, 2023·1 cites·1 claims
- 1590US10973811B1Pharmaceutical compositions and methods of using the sameGENUS LIFESCIENCES INC·Filed 2019·Granted Apr 13, 2021·3 cites·10 claims
- 1688US10231931B1Thyroid hormone oral dosage forms and methods of using the sameGENUS LIFESCIENCES INC·Filed 2018·Granted Mar 19, 2019·5 cites·8 claims
- 1786US11426413B2Oral liquid compositions including chlorpromazineGENUS LIFESCIENCES INC·Filed 2021·Granted Aug 30, 2022·2 cites·22 claims
- 1886US10406108B1Thyroid hormone oral dosage forms and methods of using the sameGENUS LIFESCIENCES INC·Filed 2019·Granted Sep 10, 2019·3 cites·11 claims
- 1984US11737986B1Thyroid hormone oral dosage forms and methods of using the sameGENUS LIFESCIENCES INC·Filed 2021·Granted Aug 29, 2023·1 cites·20 claims
- 2084US11712420B1Thyroid hormone oral dosage forms and methods of using the sameGENUS LIFESCIENCES INC·Filed 2021·Granted Aug 1, 2023·1 cites·20 claims
- 2177US12274790B1Thyroid hormone oral dosage forms and methods of using the sameGENUS LIFESCIENCES INC·Filed 2023·Granted Apr 15, 2025·0 cites·19 claims
- 2277US10603283B2Compositions and methods for delivery of omeprazole plus acetylsalicylic acidGENUS LIFESCIENCES INC·Filed 2018·Granted Mar 31, 2020·1 cites·27 claims
- 2369US12539314B1Aqueous oral compositions including potassium chlorideGENUS LIFESCIENCES INC·Filed 2023·Granted Feb 3, 2026·0 cites·29 claims
- 2468US11766441B2Oral liquid compositions including chlorpromazineGENUS LIFESCIENCES INC·Filed 2021·Granted Sep 26, 2023·0 cites·24 claims
- 2561US2019030008A1Controlled dosing of clopidogrel with gastric acid inhibition therapiesGENUS LIFESCIENCES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENUS LIFESCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →